These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10933664)

  • 1. Antiviral susceptibilities of herpes simplex virus from immunocompetent subjects with recurrent herpes labialie: a UK-based survey.
    Boon RJ; Bacon TH; Robey HL; Coleman TJ; Connolly A; Crosson P; Sacks SL
    J Antimicrob Chemother; 2000 Aug; 46(2):324-5. PubMed ID: 10933664
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical Inquiry: which drugs are most effective for recurrent herpes labialis?
    Tubridy E; Kelsberg G; St Anna L
    J Fam Pract; 2014 Feb; 63(2):104-5. PubMed ID: 24527475
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiviral susceptibilities of herpes simplex virus isolates from infants with recurrent mucocutaneous lesions after neonatal infection.
    Rabalais GP; Nusinoff-Lehrman S; Arvin AM; Levin MJ
    Pediatr Infect Dis J; 1989 Apr; 8(4):221-3. PubMed ID: 2541398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fulminant course of herpes simplex virus reactivation in an apparently immunocompetent woman.
    Tischendorf JJ; Grosse V; Flik J; Verhagen W; Manns MP; Trautwein C
    Int J Infect Dis; 2003 Jun; 7(2):160-2. PubMed ID: 12839720
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of nucleoside antiviral drugs for treatment of recurrent herpes labialis: a systematic review and meta-analysis.
    Chen F; Xu H; Liu J; Cui Y; Luo X; Zhou Y; Chen Q; Jiang L
    J Oral Pathol Med; 2017 Sep; 46(8):561-568. PubMed ID: 27935123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials.
    Sarisky RT; Bacon TH; Boon RJ; Duffy KE; Esser KM; Leary J; Locke LA; Nguyen TT; Quail MR; Saltzman R
    Arch Virol; 2003 Sep; 148(9):1757-69. PubMed ID: 14505088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral susceptibility of Herpes simplex viruses and its clinical correlates: a single center's experience.
    Rabella N; Otegui M; Labeaga R; Rodríguez P; Margall N; Gurguí M; Prats G
    Clin Infect Dis; 2002 Apr; 34(8):1055-60. PubMed ID: 11914993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex type-1 virus infection.
    Huber MA
    Quintessence Int; 2003 Jun; 34(6):453-67. PubMed ID: 12859090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes simplex virus: clinical presentation and treatment.
    Ryan WA
    Dent Today; 2001 May; 20(5):64-7. PubMed ID: 11443814
    [No Abstract]   [Full Text] [Related]  

  • 10. A possible antiviral action of lithium carbonate in herpes simplex virus infections.
    Amsterdam JD; Maislin G; Rybakowski J
    Biol Psychiatry; 1990 Feb; 27(4):447-53. PubMed ID: 2155671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sensitivity of herpes simplex virus to antiviral and other several drugs].
    Kaneko M
    Nippon Ganka Gakkai Zasshi; 1972 Jul; 76(7):399-403. PubMed ID: 4343906
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialis.
    Hull CM; Brunton S
    Postgrad Med; 2010 Sep; 122(5):1-6. PubMed ID: 20873400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ineffectiveness of topical adenine arabinoside 5'-monophosphate in the treatment of recurrent herpes simplex labialis.
    Spruance SL; Crumpacker CS; Haines H; Bader C; Mehr K; MacCalman J; Schnipper LE; Klauber MR; Overall JC
    N Engl J Med; 1979 May; 300(21):1180-4. PubMed ID: 86158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical management measures for patients with recurrent herpes labialis.
    St Pierre SA; Bartlett BL; Schlosser BJ
    Skin Therapy Lett; 2009; 14(8):1-3. PubMed ID: 20054504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary mediated autoinoculation of herpes simplex virus on the face in the absence of "cold sores," after trauma.
    Chambers A; Perry M
    J Oral Maxillofac Surg; 2008 Jan; 66(1):136-8. PubMed ID: 18083428
    [No Abstract]   [Full Text] [Related]  

  • 16. Topical n-docosanol for management of recurrent herpes labialis.
    Treister NS; Woo SB
    Expert Opin Pharmacother; 2010 Apr; 11(5):853-60. PubMed ID: 20210688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-lambda in immunocompetent individuals with a history of recurrent herpes labialis.
    Pica F; Volpi A; Gaziano R; Garaci E
    Antivir Ther; 2010; 15(5):737-43. PubMed ID: 20710055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New strategies against drug resistance to herpes simplex virus.
    Jiang YC; Feng H; Lin YC; Guo XR
    Int J Oral Sci; 2016 Mar; 8(1):1-6. PubMed ID: 27025259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex reactivation after photodynamic therapy for actinic cheilitis in a patient with non-Hodgkin lymphoma: a possible indication for prophylaxis.
    Brumana MB; Marinello E; Piaserico S; Linder MD; Cozzani E; Zattra E; Belloni Fortina A
    G Ital Dermatol Venereol; 2019 Dec; 154(6):736-737. PubMed ID: 29512976
    [No Abstract]   [Full Text] [Related]  

  • 20. Focused review: neuraxial morphine and oral herpes reactivation in the obstetric population.
    Bauchat JR
    Anesth Analg; 2010 Nov; 111(5):1238-41. PubMed ID: 20881282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.